Efficacy, Safety, and Pharmacokinetics by Body Mass Index Category in Phase 3/3b Long-Acting Cabotegravir Plus Rilpivirine Trials
JOURNAL OF INFECTIOUS DISEASES(2024)
关键词
BMI,cabotegravir,HIV-1,long-acting,rilpivirine
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要